logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

María Carmen Riesco Martínez

imperial college london
H指数:20
被引数:1,244

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis

围术期FLOT疗法是否能提高可切除食管腺癌的治愈率？——混合治愈模型分析

British Journal of Cancer
IF6.8
2025-11-260
OAAI
Lucía Mateos; Paula Jiménez-Fonseca; Javier Gallego; Arturo Lecumberri; Ana Custodio; Eva Martínez de Castro; Raquel Hernández San Gil; Ana Fernández Montes; María Luisa Limón; Rosario Vidal-Tocino; Juana María Cano; Javier López Robles; Mireia Gil; Daniel Acosta Eyzaguirre; Gema Marín Zafra; Antonio José Mérida-García; Alejandro Francisco Fernández; Paula Ribera Fernández; Cinta Hierro; María Carmen Riesco; Montse García Araque; Maribel Ruiz Martín; Paola Pimentel; Laura Visa; Paula Cerdá; Mónica Granja; Ana Belén Rupérez Blanco; Lourdes Gutiérrez; Alberto Carmona-Bayonas
Individualised dosimetry for holmium-166 RE in patients with unresectable hepatocellular carcinoma; a multi-centre, interventional, non-randomised, non-comparative, open label, phase II study: RHEPaiR

钬-166放射性栓塞个体化剂量测定在不可切除性肝细胞癌患者中的应用；一项多中心、干预性、非随机、非对比、开放标签、II期研究：RHEPaiR

BMJ OPEN
IF2.3
2025-11-180
OA
Qurashi, Maria; Martinez, Maria; Ward, Caroline; Wyard, Charlotte; Izadi, Hooshang; Bowen, Chloe; Khan, Sairah R.; Tait, Paul; Smits, Maarten; De Bruijne, Joep; Thomas, Robert; Lam, Marnix G. E. H.; Sharma, Rohini
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)
NATURE COMMUNICATIONS
IF15.7
2024-08-080
OAAI
Riesco-Martinez, Maria Carmen; Capdevila, Jaume; Alonso, Vicente; Jimenez-Fonseca, Paula; Teule, Alex; Grande, Enrique; Sevilla, Isabel; Benavent, Marta; Alonso-Gordoa, Teresa; Custodio, Ana; Anton-Pascual, Beatriz; Hernando, Jorge; Polo, Eduardo; Castillo-Trujillo, Oscar Alfredo; Lamas-Paz, Arantza; Teijo, Ana; Rodriguez-Gil, Yolanda; Soldevilla, Beatriz; Garcia-Carbonero, Rocio
The DUREC trial: Durvalumab plus total neoadjuvant therapy in locally advanced rectal cancer - a multicenter, single-arm, phase II study (GEMCAD-1703)
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
PRE
Capdevila Castillon, J.; Alonso, V.; Macias Declara, I.; Melian, M.; Gallego Plazas, J.; Vera, R.; Riesco Martinez, M. C.; Maurel, J.; Grana Suarez, B.; Hernando, J.; Garcia Alvarez, A.; Navalpotro, B.; Soler Gonzalez, G.; Polo, E.; Garcia Fadrique, A.; Espin, E.; Fernandez Martos, C.; Villacampa Javierre, G.; Losa, F.
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
European Journal of Nuclear Medicine and Molecular Imaging
IF7.6
2023-03-0624
OAAI
Mitjavila, Mercedes; Jimenez-Fonseca, Paula; Bello, Pilar; Pubul, Virginia; Percovich, Juan Carlos; Garcia-Burillo, Amparo; Hernando, Jorge; Arbizu, Javier; Rodeno, Emilia; Estorch, Montserrat; Llana, Belen; Castellon, Maribel; Garcia-Canamaque, Lina; Gajate, Pablo; Riesco, Maria Carmen; Miguel, Maria Begona; Balaguer-Munoz, David; Custodio, Ana; Cano, Juana Maria; Repetto, Alexandra; Garcia-Alonso, Pilar; Muros, Maria Angustias; Vercher-Conejero, Jose Luis; Carmona-Bayonas, Alberto
Final overall survival results from the NICE-NEC trial (GETNE-T1913): A phase II study of nivolumab and platinum-doublet chemotherapy (CT) in untreated advanced G3 neuroendocrine neoplasms (NENs) of gastroenteropancreatic (GEP) or unknown (UK) origin
ANNALS OF ONCOLOGY
IF65.4
2022-09-0115
OAAI
Riesco Martinez, M. C.; Capdevila Castillon, J.; Alonso, V.; Jimenez-Fonseca, P.; Teule, A.; Grande, E.; Sevilla, I.; Benavent, M.; Alonso-Gordoa, T.; Custodio, A.; Anton Pascual, B.; Hernando, J.; Polo, E.; Castillo Trujillo, O. A.; Garcia-Carbonero, R.
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

循环microrna的特征预测转移性结直肠癌患者对FOLFIRI联合阿柏西普治疗的反应

ANNALS OF ONCOLOGY
IF65.4
2022-09-010
OA
Rodriguez-Ariza, A.; Espana, M. A. Gomez; Fernandez, M. E. Elez; Castro, M. C. Gravalos; Alfonso, P. Garcia; Losa, F.; Diaz, I. C. Ales; Suarez, B. Grana; Gallego, I.; Garcia-Ortiz, M. V.; Marques, E. Polo; Fernandez, M. Salgado; Herrero, F. Rivera; Aguileria, M. J. Safont; Salvia, M. A. Salud; Ruiz-Casado, A.; Tabernero, J.; Martinez, M. C. Riesco; Toledano-Fonseca, M.; Aguilar, E. Ara
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial
BRITISH JOURNAL OF CANCER
IF6.8
2021-12-224
OA
Elez, Elena; Auxiliadora Gomez-Espana, Maria; Gravalos, Cristina; Garcia-Alfonso, Pilar; Jose Ortiz-Morales, Maria; Losa, Ferran; Ales Diaz, Inmaculada; Grana, Begona; Toledano-Fonseca, Marta; Valladares-Ayerbes, Manuel; Polo, Eduardo; Salgado, Mercedes; Martinez de Castro, Eva; Jose Safont, Maria; Salud, Antonieta; Ruiz-Casado, Ana; Tabernero, Josep; del Carmen Riesco, Maria; Rodriguez-Ariza, Antonio; Aranda, Enrique
Nivolumab plus platinum-doublet chemotherapy as first-line therapy in unresectable, locally advanced or metastatic G3 neuroendocrine Neoplasms (NENs) of the gastroenteropancreatic (GEP) tract or unknown (UK) origin: Preliminary results from the phase II NICE-NEC trial (GETNE T1913)
ANNALS OF ONCOLOGY
IF65.4
2021-09-017
OAAI
Riesco-Martinez, M. C.; Capdevila, J.; Alonso, V.; Jimenez-Fonseca, P.; Teule, A.; Grande, E.; Sevilla, I.; Benavent Vinuales, M.; Alonso-Gordoa, T.; Custodio, A.; Hernando, J.; Polo, E.; Castillo Trujillo, O. A.; Garcia-Carbonero, R.
Randomized phase II trial of second-line FOLFIRI-panitumumab vs FOLFIRI alone in Ras wild type (wt) metastatic colorectal cancer (mCRC) patients beyond progression to first-line FOLFOX-panitumumab: BEYOND study (GEMCAD 17-01)
ANNALS OF ONCOLOGY
IF65.4
2021-09-010
OAAI
Aparicio, J.; Virgili Manrique, A. C.; Capdevila, J.; Munoz Boza, F.; Galvan, P.; Richart, P.; Oliveres, H.; Paez, D.; Hernando, J.; Garcia Serrano, S.; Vera, R.; Hernandez, X.; Alvarez Gallego, R.; Riesco-Martinez, M. C.; Garcia de Albeniz, X.; Maurel, J.
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study
NEUROENDOCRINOLOGY
IF2.8
2021-01-2811
OA
Jimenez-Fonseca, Paula; Carmona-Bayonas, Alberto; Lamarca, Angela; Barriuso, Jorge; Castano, Angel; Benavent, Marta; Alonso, Vicente; del Carmen Riesco, Maria; Alonso-Gordoa, Teresa; Custodio, Ana; Sanchez Canovas, Manuel; Hernando, Jorge; Lopez, Carlos; La Casta, Adelaida; Fernandez Montes, Ana; Marazuela, Monica; Crespo, Guillermo; Angel Diaz, Jose; Feliciangeli, Eduardo; Gallego, Javier; Llanos, Marta; Segura, Angel; Vilardell, Felip; Carlos Percovich, Juan; Grande, Enrique; Capdevila, Jaume; Valle, Juan; Garcia-Carbonero, Rocio
NICE-NEC, a phase II study of platinum-doublet chemotherapy in combination with nivolumab as first-line treatment in subjects with unresectable, locally advanced or metastatic grade 3 neuroendocrine neoplasms (NENs) of the gastroenteropancreatic tract or of unknown origin. GETNE-T1913
ANNALS OF ONCOLOGY
IF65.4
2020-09-010
OAAI
Riesco Martinez, M. C.; Capdevila, J.; Alonso, V.; Teule, A.; Grande, E.; Jimenez-Fonseca, P.; Benavent, M.; Alonso Gordoa, T.; Custodio, A.; Hierro Carbo, C.; Lopez, C.; Sevilla Garcia, I.; Garcia-Carbonero, R.

研究方向

暂未获取到该数据
R
Rocio García‐Carbonero
H 指数:64论文数:595被引数:1.9万
A
Anna La Salvia
H 指数:24论文数:139被引数:1,551
P
Paula Jiménez‐Fonseca
H 指数:41论文数:385被引数:5,543
P
Paula Espinosa-Olarte
H 指数:8论文数:17被引数:287
J
Jorge Hernando
H 指数:16论文数:165被引数:1,279
E
Enrique Grande
H 指数:48论文数:472被引数:1.3万
B
Beatriz Soldevilla
H 指数:17论文数:61被引数:1,171
A
Ana Custodio
H 指数:29论文数:154被引数:2,288
J
Jaume Capdevila
H 指数:29论文数:359被引数:6,203
M
Marta Benavent
H 指数:18论文数:101被引数:1,072